Sunday, October 21, 2018
- 9:00AM-11:00AM
-
Abstract Number: 153
Chemotaxis of Vδ2 T Cells to the Joints Contributes to the Pathogenesis of Rheumatoid Arthritis
T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 529
Chest Computed Tomography Abnormalities in Patients with Rheumatoid Arthritis By Serologic Status
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 673
Chronic Back Pain (CBP) in First Degree Relatives (FDRs) of Patient with Ankylosing Spondylitis (AS): Comparison with the US Population, HLA-B27 Frequency and Persistence of Symptoms over Time
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment- 9:00AM-11:00AM
-
Abstract Number: 73
Circular RNAs Expression Profile in Chinese Rheumatoid Arthritis Patients at Different Disease Activity
Rheumatoid Arthritis – Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 25
Circulating CD24hiCD38hi Regulatory B-Cells Influence Th17-Cell Responses in Patients with Granulomatosis with Polyangiitis
B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 205
Circulating Plasma Metabolites and Risk of Rheumatoid Arthritis in the Nurses Health Study
Epidemiology and Public Health Poster I: Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 94
Circulating Soluble MICA Is Associated to Lupus Nephritis and to a TLR/IFN-I Signature in T Cells in a Cohort of Adult SLE Patients
Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 19
Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis
B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 45
CKD-506, First-in-Class Histone Deacetylase (HDAC) 6 Inhibitor, Ameliorates Rheumatoid Arthritis through Regulation of Inflammation and T Cell Function
Rheumatoid Arthritis – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 815
Classic and Atypical Polymyalgia Rheumatica, Are Different Syndromes? Study of 93 Patients with PET/CT from a Single Center
Vasculitis Poster I: Non-ANCA-Associated and Related Disorders- 9:00AM-11:00AM
-
Abstract Number: 788
Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients with Systemic Sclerosis
Systemic Sclerosis and Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 607
Clinical and Functional Response to Tofacitinib and Adalimumab in Patients with Rheumatoid Arthritis: Probability Plot Analysis of Results from the ORAL Strategy Trial
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 165
Clinical and Immunological Features of Antiphospholipid Syndrome in the Elderly: A Retrospective National Multicenter Study
Antiphospholipid Syndrome Poster- 9:00AM-11:00AM
-
Abstract Number: 161
Clinical and Laboratory Characteristics of Persistently Antiphospholipid Antibody Positive Patients: Retrospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)